2026 Oncology Rehabilitation: Applying the Current Evidence - Asynchronous

Course overview

The American Cancer Society estimates there are currently 16 million Americans who are cancer survivors. Because of improved detection and treatment, nearly 70% of patients with a cancer diagnosis will go on to live their full life expectancy. Cancer treatments however are not without peril as the side effects of surgery; chemotherapy and radiotherapy have a deleterious impact on function in a majority of patients. These side effects may occur in both the short and long term and many persist over the remaining lifetime of the patient. With escalating numbers of survivors, we also see escalating functional limitations and disability in the survivorship population necessitating a greater focus on cancer by the rehabilitation community. Asynchronous portion will be delivered in short video modules that will be in total duration of 180 minutes and will include the following content: Cancer Epidemiology, Tumor pathology, growth & histology, Disease diagnosis & staging, Disease treatment: surgery, chemotherapy, radiation therapy, hormonal therapy, immunotherapies. To be viewed prior to synchronous course